Cargando…

Acute Kidney Injury and Sepsis after Cardiac Surgery: The Roles of Tissue Inhibitor Metalloproteinase-2, Insulin-like Growth Factor Binding Protein-7, and Mid-Regional Pro-Adrenomedullin

Background: Identifying a panel of markers detecting kidney injury before the glomerular filtration rate reduction is a challenge to improving the diagnosis and management of acute kidney injury (AKI) in septic patients. This study evaluated the roles of tissue inhibitor metal proteinase-2, insulin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lacquaniti, Antonio, Ceresa, Fabrizio, Campo, Susanna, Barbera, Giovanna, Caruso, Daniele, Palazzo, Elenia, Patanè, Francesco, Monardo, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455441/ https://www.ncbi.nlm.nih.gov/pubmed/37629236 http://dx.doi.org/10.3390/jcm12165193

Ejemplares similares

Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study
por: Christ-Crain, Mirjam, et al.
Publicado: (2005)

Diagnostic and prognostic usefulness of mid-regional pro-adrenomedullin levels in patients with severe sepsis
por: Valenzuela Sanchez, F, et al.
Publicado: (2015)

Pro-adrenomedullin as prognostic biomarker in the sepsis
por: De La Torre-Prados, M, et al.
Publicado: (2013)

Free Light Chains, High Mobility Group Box 1, and Mortality in Hemodialysis Patients
por: Lacquaniti, Antonio, et al.
Publicado: (2022)

Mid-Regional Pro-Adrenomedullin (MR-proADM) as a Biomarker for Sepsis and Septic Shock: Narrative Review
por: Önal, Uğur, et al.
Publicado: (2018)

The Association of Mid-Regional Pro-Adrenomedullin and Mid-Regional Pro-Atrial Natriuretic Peptide with Mortality in an Incident Dialysis Cohort
por: Gouya, Ghazaleh, et al.
Publicado: (2011)

Comparison of presepsin and Mid-regional pro-adrenomedullin in the diagnosis of sepsis or septic shock: a systematic review and meta-analysis
por: Liang, Jun, et al.
Publicado: (2023)

Immune System Dysfunction and Inflammation in Hemodialysis Patients: Two Sides of the Same Coin
por: Campo, Susanna, et al.
Publicado: (2022)

Mid-Regional Pro-Adrenomedullin as a Prognostic Factor for Severe COVID-19 ARDS
por: de Montmollin, Etienne, et al.
Publicado: (2022)

Plasma mid‐regional pro‐adrenomedullin: A biomarker of the ischemic penumbra in hyperacute stroke
por: Ishiyama, Hiroyuki, et al.
Publicado: (2022)

Mid regional pro-adrenomedullin for the prediction of organ failure in infection. Results from a single centre study
por: Viaggi, Bruno, et al.
Publicado: (2018)

Best diagnostic accuracy of sepsis combining SIRS criteria or qSOFA score with Procalcitonin and Mid-Regional pro-Adrenomedullin outside ICU
por: Spoto, Silvia, et al.
Publicado: (2020)

Adrenomedullin and Adrenomedullin-Targeted Therapy As Treatment Strategies Relevant for Sepsis
por: Geven, Christopher, et al.
Publicado: (2018)

Pooled analysis of mid-regional pro-adrenomedullin values in COVID-19 patients with critical illness
por: Lippi, Giuseppe, et al.
Publicado: (2021)

The Switch from Ferric Gluconate to Ferric Carboxymaltose in Hemodialysis Patients Acts on Iron Metabolism, Erythropoietin, and Costs: A Retrospective Analysis
por: Lacquaniti, Antonio, et al.
Publicado: (2023)

Mid-regional pro-adrenomedullin and lactate levels for risk stratification in patients with out-of-hospital cardiac arrest
por: Zelniker, Thomas A, et al.
Publicado: (2023)

Adrenomedullin: a vasodilator to treat sepsis?
por: Pugin, Jérôme
Publicado: (2014)

Significance of adrenomedullin and the role of adrecizumab in sepsis
por: Nair, Abhijit
Publicado: (2021)

Endothelial dysfunction and Mid-Regional proAdrenomedullin: What role in SARS-CoV-2 infected Patients?
por: Zaninotto, Martina, et al.
Publicado: (2021)

Clinical Management of Hemodialyzed Patients: From Pharmacological Interventions to Advanced Technologies
por: Monardo, Paolo, et al.
Publicado: (2022)

Acute Kidney Injury: Advances in Clinical Management
por: Lacquaniti, Antonio, et al.
Publicado: (2022)

Adrenomedullin in Sepsis: Finally, a Friend or an Enemy?
por: Ajith Kumar, AK
Publicado: (2020)

Mid-regional pro-adrenomedullin (MR-proADM), a marker of positive fluid balance in critically ill patients: results of the ENVOL study
por: Vigué, Bernard, et al.
Publicado: (2016)

Prognostic value of mid-regional pro-adrenomedullin (MR-proADM) in patients with community-acquired pneumonia: a systematic review and meta-analysis
por: Liu, Dan, et al.
Publicado: (2016)

Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in COVID-19 critically ill patients: An observational prospective study
por: Montrucchio, Giorgia, et al.
Publicado: (2021)

Diagnostic value of mid-regional pro-Adrenomedullin as a biomarker of invasive bacterial infection in children: a systematic review
por: Corr, Michael Paul, et al.
Publicado: (2022)

Ferric carboxymaltose versus ferric gluconate in hemodialysis patients: reduction of erythropoietin dose in 4 years of follow-up
por: Lacquaniti, Antonio, et al.
Publicado: (2020)

Mid-regional pro-adrenomedullin and copeptin to predict short-term prognosis of COPD exacerbations: a multicenter prospective blinded study
por: Dres, Martin, et al.
Publicado: (2017)

Mid-regional pro-adrenomedullin is a novel biomarker for arterial stiffness as the criterion for vascular failure in a cross-sectional study
por: Koyama, Teruhide, et al.
Publicado: (2021)

Mid-Regional Pro-Adrenomedullin, Methemoglobin and Carboxyhemoglobin as Prognosis Biomarkers in Critically Ill Patients with COVID-19: An Observational Prospective Study
por: Oblitas, Crhistian-Mario, et al.
Publicado: (2021)

The value of plasma pro-enkephalin and adrenomedullin for the prediction of sepsis-associated acute kidney injury in critically ill patients
por: Liu, Ruijin, et al.
Publicado: (2020)

Mid-Regional Pro-Adrenomedullin and N-Terminal Pro-B-Type Natriuretic Peptide Measurement: A Multimarker Approach to Diagnosis and Prognosis in Acute Heart Failure
por: Spoto, Silvia, et al.
Publicado: (2023)

Identification of COVID-19 patients at risk of hospital admission and mortality: a European multicentre retrospective analysis of mid-regional pro-adrenomedullin
por: Sozio, Emanuela, et al.
Publicado: (2022)

Systematic review with meta-analysis of mid-regional pro-adrenomedullin (MR-proadm) as a prognostic marker in Covid-19-hospitalized patients
por: Fialek, Bartosz, et al.
Publicado: (2023)

Synergistic effect of myocardial injury and mid-regional proAdrenomedullin elevation in determining clinical outcomes of SARS-CoV-2 patients
por: Spoto, Silvia, et al.
Publicado: (2022)

Mid-regional pro-adrenomedullin as a predictor of in-hospital mortality in adult patients with COVID-19: a single-centre prospective study
por: Popov, Dmitry, et al.
Publicado: (2022)

Pro-adrenomedullin as a clinical predictor after cardiac surgery
por: Van Fessem, J, et al.
Publicado: (2013)

Prognostic value of pro-adrenomedullin and copeptin in acute infective endocarditis
por: Zampino, Rosa, et al.
Publicado: (2021)

Plasma Concentrations of the Vasoactive Peptide Fragments Mid-Regional Pro-Adrenomedullin, C-Terminal Pro-Endothelin 1 and Copeptin in Hemodialysis Patients: Associated Factors and Prediction of Mortality
por: Artunc, Ferruh, et al.
Publicado: (2014)

A protocol for a systematic review and meta-analysis of the diagnostic accuracy of mid-regional pro-adrenomedullin in predicting invasive bacterial infection in children
por: Corr, Michael, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q698mdkkbbb7ljb8mdg953lqja